Literature DB >> 18355191

Schnitzler syndrome: a dramatic improvement with anakinra.

H Wastiaux, S Barbarot, V Gagey-Caron, J M Berthelot, M Hamidou, J-F Stalder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18355191     DOI： 10.1111/j.1468-3083.2008.02708.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  7 in total

1.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

Review 2.  Canakinumab.

Authors:  Eugen Dhimolea
Journal:  MAbs       Date:  2010-01-15       Impact factor: 5.857

Review 3.  Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*).

Authors:  Seth L Masters; Anna Simon; Ivona Aksentijevich; Daniel L Kastner
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

4.  Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review.

Authors:  Emilio Besada; Hans Nossent
Journal:  Clin Rheumatol       Date:  2010-02-01       Impact factor: 3.650

Review 5.  Schnitzler's syndrome: lessons from 281 cases.

Authors:  Heleen D de Koning
Journal:  Clin Transl Allergy       Date:  2014-12-05       Impact factor: 5.871

6.  Schnitzler's syndrome: a case report.

Authors:  Gabriel Tinoco; Rehan Kanji; Deepthi Moola
Journal:  Case Rep Med       Date:  2013-06-09

7.  Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome.

Authors:  David Launay; Virginie Dutoit-Lefevre; Emmanuel Faure; Olivier Robineau; Carine Hauspie; Vincent Sobanski; Eric Hachulla; Myriam Labalette; Pierre-Yves Hatron; Sylvain Dubucquoi
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.